Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net Income (Loss)	$ 77,141	$ 3,892	$ 83,234	$ 10,507
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on asset disposals			(1,145)	0
Depreciation of fixed assets	909	437	3,042	1,371
Amortization of internal-use software and intangibles	343	430	1,120	1,326
Deferred income taxes	65,100		(66,506)	(378)
Share-based compensation	3,638	3,466	9,489	9,410
Changes in operating assets and liabilities			(10,855)	(4,556)
Net cash provided by operating activities			18,379	17,680
Investing activities
Capital expenditures			(7,658)	(3,616)
Additional investments in corporate-owned life insurance policies			(2)	(27)
Net cash used in investing activities			(7,660)	(3,643)
Financing activities
Payment of preferred stock dividends			(1,663)	(1,836)
Repurchase of common shares to satisfy employee tax withholding			(5,734)	(2,924)
Principal payments under long-term obligations			(2)	(3)
Net cash used in financing activities			(7,399)	(4,763)
Effect of exchange rate changes on cash			38	(427)
Net increase in cash and cash equivalents			3,358	8,847
Cash and cash equivalents at beginning of period			112,842	96,971
Cash and cash equivalents at end of period	$ 116,200	$ 105,818	$ 116,200	$ 105,818